Pentobarbital will decrease the level or effect of bedaquiline by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Avoid coadministration of bedaquiline with stark CYP3A4 inducers due to potential for decreased therapeutic effect pentobarbital will decrease the level or effect of irinotecan liposomal by affecting hepatic/intestinal enzyme CYP3A4 https://rnembutalettpiller36025.acidblog.net/61380950/allt-om-var-ist-natrium-pentobarbital